Research & Development Expenses
The latest quarterly r&d expense is $0 with a quarter-over-quarter change of 0.00%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
R&D Expense
DOC R&D Expense
$0.00
Reported quarterly R&D expense; no daily interpolation.
Current R&D Expense
$0
$0
Quarter-over-Quarter Change
0.00%
vs. $0 prior quarter
Historical Data
57
Quarters of data available
Quarterly R&D Expense History
| Period | R&D Expense | QoQ Change | % Change |
|---|---|---|---|
| Q1 2026 | $0 | +$0 | — |
| Q4 2025 | $0 | +$0 | — |
| Q3 2025 | $0 | +$0 | — |
| Q2 2025 | $0 | +$0 | — |
| Q1 2025 | $0 | +$0 | — |
| Q4 2024 | $0 | +$0 | — |
| Q3 2024 | $0 | +$0 | — |
| Q2 2024 | $0 | +$0 | — |
| Q1 2024 | $0 | +$0 | — |
| Q4 2023 | $0 | +$0 | — |
| Q3 2023 | $0 | +$0 | — |
| Q2 2023 | $0 | +$0 | — |
| Q1 2023 | $0 | +$0 | — |
| Q4 2022 | $0 | +$0 | — |
| Q3 2022 | $0 | +$0 | — |
| Q2 2022 | $0 | +$0 | — |
| Q1 2022 | $0 | +$0 | — |
| Q4 2021 | $0 | +$0 | — |
| Q3 2021 | $0 | +$0 | — |
| Q2 2021 | $0 | +$0 | — |
| Q1 2021 | $0 | +$0 | — |
| Q4 2020 | $0 | +$0 | — |
| Q3 2020 | $0 | +$0 | — |
| Q2 2020 | $0 | +$0 | — |
| Q1 2020 | $0 | +$0 | — |
| Q4 2019 | $0 | +$0 | — |
| Q3 2019 | $0 | +$0 | — |
| Q2 2019 | $0 | +$0 | — |
| Q1 2019 | $0 | +$0 | — |
| Q4 2018 | $0 | +$0 | — |
| Q3 2018 | $0 | +$0 | — |
| Q2 2018 | $0 | +$0 | — |
| Q1 2018 | $0 | +$0 | — |
| Q4 2017 | $0 | +$0 | — |
| Q3 2017 | $0 | +$0 | — |
| Q2 2017 | $0 | +$0 | — |
| Q1 2017 | $0 | +$0 | — |
| Q4 2016 | $0 | +$0 | — |
| Q3 2016 | $0 | +$0 | — |
| Q2 2016 | $0 | +$0 | — |
| Q1 2016 | $0 | +$0 | — |
| Q4 2015 | $0 | +$0 | — |
| Q3 2015 | $0 | +$0 | — |
| Q2 2015 | $0 | +$0 | — |
| Q1 2015 | $0 | +$0 | — |
| Q4 2014 | $0 | +$0 | — |
| Q3 2014 | $0 | +$0 | — |
| Q2 2014 | $0 | +$0 | — |
| Q1 2014 | $0 | +$0 | — |
| Q4 2013 | $0 | +$0 | — |
| Q3 2013 | $0 | +$0 | — |
| Q2 2013 | $0 | +$0 | — |
| Q1 2013 | $0 | +$0 | — |
| Q4 2012 | $0 | +$0 | — |
| Q3 2012 | $0 | +$0 | — |
| Q2 2012 | $0 | +$0 | — |
| Q1 2012 | $0 | — | — |
Data as of Sunday, June 28, 2026
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Scott Brinker